ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Bacterial Vaginosis Drug Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-5V15812
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global and India Bacterial Vaginosis Drug Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Bacterial Vaginosis Drug Market Report & Forecast 2023-2029

Code: QYRE-Auto-5V15812
Report
November 2023
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Sanofi S A
China
Bayer
Pfizer Inc
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
TEVA
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge

and India Bacterial Vaginosis Drug Market Size

The global Bacterial Vaginosis Drug revenue was US$ 916.5 million in 2022 and is forecast to a readjusted size of US$ 1130 million by 2029 with a CAGR of 3.0% during the review period (2023-2029).

and India Bacterial Vaginosis Drug Market

and India Bacterial Vaginosis Drug Market

This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs.
In India, the Bacterial Vaginosis Drug revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
Global Bacterial Vaginosis Drug key players include Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. Global top five manufacturers hold a share about 20%. North America and Europe is the largest market, both with a share about 30%, followed by China, with a share about 10 percent. In terms of product, OTC is the largest segment, with a share about 70%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
This report focuses on global and India Bacterial Vaginosis Drug market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Bacterial Vaginosis Drug will continue to grow rapidly in the future.
Global Bacterial Vaginosis Drug Scope and Market Size
Bacterial Vaginosis Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Bacterial Vaginosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Bacterial Vaginosis Drug market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Bacterial Vaginosis Drug Market Report

Report Metric Details
Report Name and India Bacterial Vaginosis Drug Market
Forecasted market size in 2029 US$ 1130 million
CAGR 3.0%
Forecasted years 2023 - 2029
Segment by Type
  • Rx
  • OTC
Segment by Application
  • Hospital
  • Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, Pfizer, Sanofi, Piramal, Abbott, Galderma, Mission, Alkem, Xiuzheng, Teva, Perrigo, West-Ward, HPGC, Yunnan Baiyao, Starpharma, Novel, Edenvridge
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Bacterial Vaginosis Drug Market size in 2029?

Ans: The and India Bacterial Vaginosis Drug Market size in 2029 will be US$ 1130 million.

What is the market share of major companies in and India Bacterial Vaginosis Drug Market?

Ans: Global top five manufacturers hold a share about 20%.

What is the and India Bacterial Vaginosis Drug Market share by type?

Ans: In terms of product, OTC is the largest segment, with a share about 70%.

What is the and India Bacterial Vaginosis Drug Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Bacterial Vaginosis Drug Market report?

Ans: The main players in the and India Bacterial Vaginosis Drug Market are Bayer, Pfizer, Sanofi, Piramal, Abbott, Galderma, Mission, Alkem, Xiuzheng, Teva, Perrigo, West-Ward, HPGC, Yunnan Baiyao, Starpharma, Novel, Edenvridge

What are the Application segmentation covered in the and India Bacterial Vaginosis Drug Market report?

Ans: The Applications covered in the and India Bacterial Vaginosis Drug Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the and India Bacterial Vaginosis Drug Market report?

Ans: The Types covered in the and India Bacterial Vaginosis Drug Market report are Rx, OTC

1 Study Coverage
1.1 Bacterial Vaginosis Drug Product Introduction
1.2 Global Bacterial Vaginosis Drug Outlook 2018 VS 2022 VS 2029
1.2.1 Global Bacterial Vaginosis Drug Market Size for the Year 2018-2029
1.2.2 India Bacterial Vaginosis Drug Market Size for the Year 2018-2029
1.3 Bacterial Vaginosis Drug Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Bacterial Vaginosis Drug in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Bacterial Vaginosis Drug Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Bacterial Vaginosis Drug Market Dynamics
1.4.1 Bacterial Vaginosis Drug Industry Trends
1.4.2 Bacterial Vaginosis Drug Market Drivers
1.4.3 Bacterial Vaginosis Drug Market Challenges
1.4.4 Bacterial Vaginosis Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Bacterial Vaginosis Drug by Type
2.1 Bacterial Vaginosis Drug Market Segment by Type
2.1.1 Rx
2.1.2 OTC
2.2 Global Bacterial Vaginosis Drug Market Size by Type (2018, 2022 & 2029)
2.3 Global Bacterial Vaginosis Drug Market Size by Type (2018-2029)
2.4 India Bacterial Vaginosis Drug Market Size by Type (2018, 2022 & 2029)
2.5 India Bacterial Vaginosis Drug Market Size by Type (2018-2029)
3 Bacterial Vaginosis Drug by Application
3.1 Bacterial Vaginosis Drug Market Segment by Application
3.1.1 Hospital
3.1.2 Pharmacy
3.1.3 Other
3.2 Global Bacterial Vaginosis Drug Market Size by Application (2018, 2022 & 2029)
3.3 Global Bacterial Vaginosis Drug Market Size by Application (2018-2029)
3.4 India Bacterial Vaginosis Drug Market Size by Application (2018, 2022 & 2029)
3.5 India Bacterial Vaginosis Drug Market Size by Application (2018-2029)
4 Global Bacterial Vaginosis Drug Competitor Landscape by Company
4.1 Global Bacterial Vaginosis Drug Market Size by Company
4.1.1 Global Key Companies of Bacterial Vaginosis Drug, Ranked by Revenue (2022)
4.1.2 Global Bacterial Vaginosis Drug Revenue by Player (2018-2023)
4.2 Global Bacterial Vaginosis Drug Concentration Ratio (CR)
4.2.1 Bacterial Vaginosis Drug Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Bacterial Vaginosis Drug in 2022
4.2.3 Global Bacterial Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Bacterial Vaginosis Drug Head office and Area Served
4.4 Global Key Players of Bacterial Vaginosis Drug, Product and Application
4.5 Global Key Players of Bacterial Vaginosis Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Bacterial Vaginosis Drug Market Size by Company
4.7.1 Key Players of Bacterial Vaginosis Drug in India, Ranked by Revenue (2022)
4.7.2 India Bacterial Vaginosis Drug Revenue by Players (2021, 2022 & 2023)
5 Global Bacterial Vaginosis Drug Market Size by Region
5.1 Global Bacterial Vaginosis Drug Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Bacterial Vaginosis Drug Market Size by Region (2018-2029)
5.2.1 Global Bacterial Vaginosis Drug Market Size by Region: 2018-2023
5.2.2 Global Bacterial Vaginosis Drug Market Size by Region (2024-2029)
6 Americas
6.1 Americas Bacterial Vaginosis Drug Market Size YoY Growth 2018-2029
6.2 Americas Bacterial Vaginosis Drug Market Size by Type
6.2.1 Americas Bacterial Vaginosis Drug Market Size by Type (2018-2023)
6.2.2 Americas Bacterial Vaginosis Drug Market Size by Type (2024-2029)
6.2.3 Americas Bacterial Vaginosis Drug Market Share by Type (2018-2029)
6.3 Americas Bacterial Vaginosis Drug Market Size by Application
6.3.1 Americas Bacterial Vaginosis Drug Market Size by Application (2018-2023)
6.3.2 Americas Bacterial Vaginosis Drug Market Size by Application (2024-2029)
6.3.3 Americas Bacterial Vaginosis Drug Market Share by Application (2018-2029)
6.4 Americas Bacterial Vaginosis Drug Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Bacterial Vaginosis Drug Market Size YoY Growth 2018-2029
7.2 EMEA Bacterial Vaginosis Drug Market Size by Type
7.2.1 EMEA Bacterial Vaginosis Drug Market Size by Type (2018-2023)
7.2.2 EMEA Bacterial Vaginosis Drug Market Size by Type (2024-2029)
7.2.3 EMEA Bacterial Vaginosis Drug Market Share by Type (2018-2029)
7.3 EMEA Bacterial Vaginosis Drug Market Size by Application
7.3.1 EMEA Bacterial Vaginosis Drug Market Size by Application (2018-2023)
7.3.2 EMEA Bacterial Vaginosis Drug Market Size by Application (2024-2029)
7.3.3 EMEA Bacterial Vaginosis Drug Market Share by Application (2018-2029)
7.4 EMEA Bacterial Vaginosis Drug Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Bacterial Vaginosis Drug Market Size YoY Growth 2018-2029
8.2 China Bacterial Vaginosis Drug Market Size by Type
8.2.1 China Bacterial Vaginosis Drug Market Size by Type (2018-2023)
8.2.2 China Bacterial Vaginosis Drug Market Size by Type (2024-2029)
8.2.3 China Bacterial Vaginosis Drug Market Share by Type (2018-2029)
8.3 China Bacterial Vaginosis Drug Market Size by Application
8.3.1 China Bacterial Vaginosis Drug Market Size by Application (2018-2023)
8.3.2 China Bacterial Vaginosis Drug Market Size by Application (2024-2029)
8.3.3 China Bacterial Vaginosis Drug Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Bacterial Vaginosis Drug Market Size YoY Growth 2018-2029
9.2 APAC Bacterial Vaginosis Drug Market Size by Type
9.2.1 APAC Bacterial Vaginosis Drug Market Size by Type (2018-2023)
9.2.2 APAC Bacterial Vaginosis Drug Market Size by Type (2024-2029)
9.2.3 APAC Bacterial Vaginosis Drug Market Share by Type (2018-2029)
9.3 APAC Bacterial Vaginosis Drug Market Size by Application
9.3.1 APAC Bacterial Vaginosis Drug Market Size by Application (2018-2023)
9.3.2 APAC Bacterial Vaginosis Drug Market Size by Application (2024-2029)
9.3.3 APAC Bacterial Vaginosis Drug Market Share by Application (2018-2029)
9.4 APAC Bacterial Vaginosis Drug Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Bayer
10.1.1 Bayer Company Details
10.1.2 Bayer Business Overview
10.1.3 Bayer Bacterial Vaginosis Drug Introduction
10.1.4 Bayer Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.1.5 Bayer Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Details
10.2.2 Pfizer Business Overview
10.2.3 Pfizer Bacterial Vaginosis Drug Introduction
10.2.4 Pfizer Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.2.5 Pfizer Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Details
10.3.2 Sanofi Business Overview
10.3.3 Sanofi Bacterial Vaginosis Drug Introduction
10.3.4 Sanofi Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.3.5 Sanofi Recent Development
10.4 Piramal
10.4.1 Piramal Company Details
10.4.2 Piramal Business Overview
10.4.3 Piramal Bacterial Vaginosis Drug Introduction
10.4.4 Piramal Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.4.5 Piramal Recent Development
10.5 Abbott
10.5.1 Abbott Company Details
10.5.2 Abbott Business Overview
10.5.3 Abbott Bacterial Vaginosis Drug Introduction
10.5.4 Abbott Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.5.5 Abbott Recent Development
10.6 Galderma
10.6.1 Galderma Company Details
10.6.2 Galderma Business Overview
10.6.3 Galderma Bacterial Vaginosis Drug Introduction
10.6.4 Galderma Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.6.5 Galderma Recent Development
10.7 Mission
10.7.1 Mission Company Details
10.7.2 Mission Business Overview
10.7.3 Mission Bacterial Vaginosis Drug Introduction
10.7.4 Mission Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.7.5 Mission Recent Development
10.8 Alkem
10.8.1 Alkem Company Details
10.8.2 Alkem Business Overview
10.8.3 Alkem Bacterial Vaginosis Drug Introduction
10.8.4 Alkem Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.8.5 Alkem Recent Development
10.9 Xiuzheng
10.9.1 Xiuzheng Company Details
10.9.2 Xiuzheng Business Overview
10.9.3 Xiuzheng Bacterial Vaginosis Drug Introduction
10.9.4 Xiuzheng Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.9.5 Xiuzheng Recent Development
10.10 Teva
10.10.1 Teva Company Details
10.10.2 Teva Business Overview
10.10.3 Teva Bacterial Vaginosis Drug Introduction
10.10.4 Teva Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.10.5 Teva Recent Development
10.11 Perrigo
10.11.1 Perrigo Company Details
10.11.2 Perrigo Business Overview
10.11.3 Perrigo Bacterial Vaginosis Drug Introduction
10.11.4 Perrigo Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.11.5 Perrigo Recent Development
10.12 West-Ward
10.12.1 West-Ward Company Details
10.12.2 West-Ward Business Overview
10.12.3 West-Ward Bacterial Vaginosis Drug Introduction
10.12.4 West-Ward Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.12.5 West-Ward Recent Development
10.13 HPGC
10.13.1 HPGC Company Details
10.13.2 HPGC Business Overview
10.13.3 HPGC Bacterial Vaginosis Drug Introduction
10.13.4 HPGC Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.13.5 HPGC Recent Development
10.14 Yunnan Baiyao
10.14.1 Yunnan Baiyao Company Details
10.14.2 Yunnan Baiyao Business Overview
10.14.3 Yunnan Baiyao Bacterial Vaginosis Drug Introduction
10.14.4 Yunnan Baiyao Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.14.5 Yunnan Baiyao Recent Development
10.15 Starpharma
10.15.1 Starpharma Company Details
10.15.2 Starpharma Business Overview
10.15.3 Starpharma Bacterial Vaginosis Drug Introduction
10.15.4 Starpharma Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.15.5 Starpharma Recent Development
10.16 Novel
10.16.1 Novel Company Details
10.16.2 Novel Business Overview
10.16.3 Novel Bacterial Vaginosis Drug Introduction
10.16.4 Novel Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.16.5 Novel Recent Development
10.17 Edenvridge
10.17.1 Edenvridge Company Details
10.17.2 Edenvridge Business Overview
10.17.3 Edenvridge Bacterial Vaginosis Drug Introduction
10.17.4 Edenvridge Revenue in Bacterial Vaginosis Drug Business (2018-2023)
10.17.5 Edenvridge Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
Sanofi
Sanofi S A
China
Bayer
Pfizer Inc
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
TEVA
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge
List of Tables
    Table 1. Bacterial Vaginosis Drug Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Bacterial Vaginosis Drug Market Trends
    Table 3. Bacterial Vaginosis Drug Market Drivers
    Table 4. Bacterial Vaginosis Drug Market Challenges
    Table 5. Bacterial Vaginosis Drug Market Restraints
    Table 6. Global Bacterial Vaginosis Drug Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Bacterial Vaginosis Drug Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Bacterial Vaginosis Drug Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Bacterial Vaginosis Drug Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Bacterial Vaginosis Drug, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Bacterial Vaginosis Drug Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Bacterial Vaginosis Drug Revenue Share by Player, 2018-2023
    Table 13. Global Bacterial Vaginosis Drug Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Bacterial Vaginosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacterial Vaginosis Drug as of 2022)
    Table 15. Global Key Players of Bacterial Vaginosis Drug, Headquarters and Area Served
    Table 16. Global Key Players of Bacterial Vaginosis Drug, Product and Application
    Table 17. Global Key Players of Bacterial Vaginosis Drug, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Bacterial Vaginosis Drug in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Bacterial Vaginosis Drug Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Bacterial Vaginosis Drug Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Bacterial Vaginosis Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Bacterial Vaginosis Drug Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Bacterial Vaginosis Drug Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Bacterial Vaginosis Drug Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Bacterial Vaginosis Drug Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Bacterial Vaginosis Drug Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Bacterial Vaginosis Drug Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Bacterial Vaginosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Bacterial Vaginosis Drug Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Bacterial Vaginosis Drug Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Bacterial Vaginosis Drug Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Bacterial Vaginosis Drug Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Bacterial Vaginosis Drug Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Bacterial Vaginosis Drug Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Bacterial Vaginosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Bacterial Vaginosis Drug Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Bacterial Vaginosis Drug Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Bacterial Vaginosis Drug Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Bacterial Vaginosis Drug Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Bacterial Vaginosis Drug Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Bacterial Vaginosis Drug Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Bacterial Vaginosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Bacterial Vaginosis Drug Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Bacterial Vaginosis Drug Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Bacterial Vaginosis Drug Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Bacterial Vaginosis Drug Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Bacterial Vaginosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Bacterial Vaginosis Drug Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Bacterial Vaginosis Drug Market Size by Region (2024-2029) & (US$ Million)
    Table 51. Bayer Company Details
    Table 52. Bayer Business Overview
    Table 53. Bayer Bacterial Vaginosis Drug Product
    Table 54. Bayer Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 55. Bayer Recent Development
    Table 56. Pfizer Company Details
    Table 57. Pfizer Business Overview
    Table 58. Pfizer Bacterial Vaginosis Drug Product
    Table 59. Pfizer Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 60. Pfizer Recent Development
    Table 61. Sanofi Company Details
    Table 62. Sanofi Business Overview
    Table 63. Sanofi Bacterial Vaginosis Drug Product
    Table 64. Sanofi Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 65. Sanofi Recent Development
    Table 66. Piramal Company Details
    Table 67. Piramal Business Overview
    Table 68. Piramal Bacterial Vaginosis Drug Product
    Table 69. Piramal Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 70. Piramal Recent Development
    Table 71. Abbott Company Details
    Table 72. Abbott Business Overview
    Table 73. Abbott Bacterial Vaginosis Drug Product
    Table 74. Abbott Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 75. Abbott Recent Development
    Table 76. Galderma Company Details
    Table 77. Galderma Business Overview
    Table 78. Galderma Bacterial Vaginosis Drug Product
    Table 79. Galderma Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 80. Galderma Recent Development
    Table 81. Mission Company Details
    Table 82. Mission Business Overview
    Table 83. Mission Bacterial Vaginosis Drug Product
    Table 84. Mission Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 85. Mission Recent Development
    Table 86. Alkem Company Details
    Table 87. Alkem Business Overview
    Table 88. Alkem Bacterial Vaginosis Drug Product
    Table 89. Alkem Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 90. Alkem Recent Development
    Table 91. Xiuzheng Company Details
    Table 92. Xiuzheng Business Overview
    Table 93. Xiuzheng Bacterial Vaginosis Drug Product
    Table 94. Xiuzheng Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 95. Xiuzheng Recent Development
    Table 96. Teva Company Details
    Table 97. Teva Business Overview
    Table 98. Teva Bacterial Vaginosis Drug Product
    Table 99. Teva Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 100. Teva Recent Development
    Table 101. Perrigo Company Details
    Table 102. Perrigo Business Overview
    Table 103. Perrigo Bacterial Vaginosis Drug Product
    Table 104. Perrigo Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 105. Perrigo Recent Development
    Table 106. West-Ward Company Details
    Table 107. West-Ward Business Overview
    Table 108. West-Ward Bacterial Vaginosis Drug Product
    Table 109. West-Ward Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 110. West-Ward Recent Development
    Table 111. HPGC Company Details
    Table 112. HPGC Business Overview
    Table 113. HPGC Bacterial Vaginosis Drug Product
    Table 114. HPGC Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 115. HPGC Recent Development
    Table 116. Yunnan Baiyao Company Details
    Table 117. Yunnan Baiyao Business Overview
    Table 118. Yunnan Baiyao Bacterial Vaginosis Drug Product
    Table 119. Yunnan Baiyao Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 120. Yunnan Baiyao Recent Development
    Table 121. Starpharma Company Details
    Table 122. Starpharma Business Overview
    Table 123. Starpharma Bacterial Vaginosis Drug Product
    Table 124. Starpharma Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 125. Starpharma Recent Development
    Table 126. Novel Company Details
    Table 127. Novel Business Overview
    Table 128. Novel Bacterial Vaginosis Drug Product
    Table 129. Novel Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 130. Novel Recent Development
    Table 131. Edenvridge Company Details
    Table 132. Edenvridge Business Overview
    Table 133. Edenvridge Bacterial Vaginosis Drug Product
    Table 134. Edenvridge Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)
    Table 135. Edenvridge Recent Development
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bacterial Vaginosis Drug Product Picture
    Figure 2. Global Bacterial Vaginosis Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Bacterial Vaginosis Drug Market Size 2018-2029 (US$ Million)
    Figure 4. India Bacterial Vaginosis Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Bacterial Vaginosis Drug Market Size 2018-2029 (US$ Million)
    Figure 6. India Bacterial Vaginosis Drug Market Share in Global 2018-2029
    Figure 7. Bacterial Vaginosis Drug Report Years Considered
    Figure 8. Product Picture of Rx
    Figure 9. Product Picture of OTC
    Figure 10. Global Bacterial Vaginosis Drug Market Share by Type in 2022 & 2029
    Figure 11. Global Bacterial Vaginosis Drug Market Size by Type (2018-2029) & (US$ Million)
    Figure 12. Global Bacterial Vaginosis Drug Market Share by Type (2018-2029)
    Figure 13. India Bacterial Vaginosis Drug Market Share by Type in 2022 & 2029
    Figure 14. India Bacterial Vaginosis Drug Market Size by Type (2018-2029) & (US$ Million)
    Figure 15. India Bacterial Vaginosis Drug Market Share by Type (2018-2029)
    Figure 16. Product Picture of Hospital
    Figure 17. Product Picture of Pharmacy
    Figure 18. Product Picture of Other
    Figure 19. Global Bacterial Vaginosis Drug Market Share by Application in 2022 & 2029
    Figure 20. Global Bacterial Vaginosis Drug Market Size by Application (2018-2029) & (US$ Million)
    Figure 21. Global Bacterial Vaginosis Drug Market Share by Application (2018-2029)
    Figure 22. India Bacterial Vaginosis Drug Market Share by Application in 2022 & 2029
    Figure 23. India Bacterial Vaginosis Drug Market Size by Application (2018-2029) & (US$ Million)
    Figure 24. India Bacterial Vaginosis Drug Market Share by Application (2018-2029)
    Figure 25. The Top 5 and 10 Largest Companies of Bacterial Vaginosis Drug in the World: Market Share by Bacterial Vaginosis Drug Revenue in 2022
    Figure 26. Global Bacterial Vaginosis Drug Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 27. Global Bacterial Vaginosis Drug Market Share by Region (2018-2029)
    Figure 28. Americas Bacterial Vaginosis Drug Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 29. Americas Bacterial Vaginosis Drug Market Share by Type (2018-2029)
    Figure 30. Americas Bacterial Vaginosis Drug Market Share by Application (2018-2029)
    Figure 31. United States Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Canada Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Mexico Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Brazil Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 35. EMEA Bacterial Vaginosis Drug Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 36. EMEA Bacterial Vaginosis Drug Market Share by Type (2018-2029)
    Figure 37. EMEA Bacterial Vaginosis Drug Market Share by Application (2018-2029)
    Figure 38. Europe Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Middle East Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Africa Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 41. China Bacterial Vaginosis Drug Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 42. China Bacterial Vaginosis Drug Market Share by Type (2018-2029)
    Figure 43. China Bacterial Vaginosis Drug Market Share by Application (2018-2029)
    Figure 44. APAC Bacterial Vaginosis Drug Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 45. APAC Bacterial Vaginosis Drug Market Share by Type (2018-2029)
    Figure 46. APAC Bacterial Vaginosis Drug Market Share by Application (2018-2029)
    Figure 47. Japan Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 48. South Korea Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 49. China Taiwan Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Southeast Asia Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 51. India Bacterial Vaginosis Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Bayer Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 53. Pfizer Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 54. Sanofi Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 55. Piramal Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 56. Abbott Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 57. Galderma Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 58. Mission Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 59. Alkem Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 60. Xiuzheng Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 61. Teva Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 62. Perrigo Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 63. West-Ward Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 64. HPGC Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 65. Yunnan Baiyao Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 66. Starpharma Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 67. Novel Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 68. Edenvridge Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions